Forbes July 6, 2020
Ongoing disruptions in the globalized pharma supply chains causing drug shortages in the United States are at their highest in five years. Prescription medications dispensed through health systems, and pharmacies are seeing outages. Scarcities exist in a wide range of drugs used in cardiovascular, anti-infective, and cancer treatments, etc. Commoditized old generic drugs, intravenous (“IV”) saline solutions, anesthetics, and antacids like sodium bicarbonate amongst others, have also been occasionally in limited supply.
“Race to the bottom,” unhealthy purchase prices are causing a dysfunctional business environment for the generic drug market.
Some of the symptoms are:
- Failure to attract investment capital
- Lack of resources to upgrade manufacturing facilities and drug quality
- Inability to conform with mandated manufacturing...
Today's Sponsors
Today's Sponsor